Editorial Commentary
Immune checkpoint inhibitors: here to stay
Translational Cancer Research
2023;
12
(10)
:2438-2441
.
(31 October 2023)
A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
Translational Cancer Research
2023;
12
(10)
:2442-2447
.
(31 October 2023)
Rucaparib for metastatic castration-resistant prostate cancer: did TRITON3 deliver a trifecta?
Translational Cancer Research
2023;
12
(10)
:2448-2453
.
(31 October 2023)
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple “MIRAGE”?
Translational Cancer Research
2023;
12
(10)
:2454-2457
.
(31 October 2023)
Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups
Translational Cancer Research
2023;
12
(10)
:2458-2460
.
(31 October 2023)
Original Article
IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis
Translational Cancer Research
2023;
12
(10)
:2461-2476
.
(31 October 2023)
A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer
Translational Cancer Research
2023;
12
(10)
:2477-2492
.
(31 October 2023)
A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma
Translational Cancer Research
2023;
12
(10)
:2493-2507
.
(31 October 2023)
Effects of COVID-19 vaccination on cervical lymph nodes in patients with thyroid cancer
Translational Cancer Research
2023;
12
(10)
:2508-2517
.
(31 October 2023)
Validation of prognostic signature and exploring the immune-related mechanisms for NR3C2 in clear cell renal cell carcinoma
Translational Cancer Research
2023;
12
(10)
:2518-2532
.
(31 October 2023)
Prognostic significance of globulin/low-density lipoprotein ratio in patients with hepatocellular carcinoma after local ablative therapy: a retrospective cohort study
Translational Cancer Research
2023;
12
(10)
:2533-2544
.
(31 October 2023)
A ternary model of proton therapy based on boron medium radiosensitization and enhancement paths: a Monte Carlo simulation
Translational Cancer Research
2023;
12
(10)
:2545-2555
.
(31 October 2023)
RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer
Translational Cancer Research
2023;
12
(10)
:2556-2571
.
(31 October 2023)
Colorectal cancer mouse metastasis model combining bioluminescent and micro-computed tomography imaging for monitoring the effects of 5-fluorouracil treatment
Translational Cancer Research
2023;
12
(10)
:2572-2581
.
(31 October 2023)
The transcription activity of OTX2 on p16 expression is significantly blocked by methylation of CpG shore in non-promoter of lung cancer cell lines
Translational Cancer Research
2023;
12
(10)
:2582-2595
.
(31 October 2023)
Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma
Translational Cancer Research
2023;
12
(10)
:2596-2612
.
(31 October 2023)
Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma
Translational Cancer Research
2023;
12
(10)
:2613-2628
.
(31 October 2023)
Genes associated with inflammation for prognosis prediction for clear cell renal cell carcinoma: a multi-database analysis
Translational Cancer Research
2023;
12
(10)
:2629-2645
.
(31 October 2023)
Molecular markers that predict response to combined radiotherapy and immunotherapy in patients with lung adenocarcinoma: a bioinformatics analysis
Translational Cancer Research
2023;
12
(10)
:2646-2659
.
(31 October 2023)
Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish
Translational Cancer Research
2023;
12
(10)
:2660-2672
.
(31 October 2023)
Prognostic value of APOBEC3A in patients with cervical squamous cell carcinoma in a major urban center in China: a retrospective study
Translational Cancer Research
2023;
12
(10)
:2673-2681
.
(31 October 2023)
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre
Translational Cancer Research
2023;
12
(10)
:2682-2692
.
(31 October 2023)
Survival trends and conditional survival in primary non-metastatic esophageal cancer: a SEER population-based study and external validation
Translational Cancer Research
2023;
12
(10)
:2693-2705
.
(31 October 2023)
Establishment of a prognostic signature for patients with advanced lung squamous cell carcinoma based on tumor-infiltrating immune cells
Translational Cancer Research
2023;
12
(10)
:2706-2716
.
(31 October 2023)
Oncologic outcome of breast reconstruction after mastectomy in breast cancer: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(10)
:2717-2725
.
(31 October 2023)
Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study
Translational Cancer Research
2023;
12
(10)
:2726-2741
.
(31 October 2023)
Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
Translational Cancer Research
2023;
12
(10)
:2742-2753
.
(31 October 2023)
SMIM20: a new biological signal associated with the prognosis of glioblastoma
Translational Cancer Research
2023;
12
(10)
:2754-2763
.
(31 October 2023)
Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
Translational Cancer Research
2023;
12
(10)
:2764-2780
.
(31 October 2023)
DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
Translational Cancer Research
2023;
12
(10)
:2781-2805
.
(31 October 2023)
Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population
Translational Cancer Research
2023;
12
(10)
:2806-2822
.
(31 October 2023)
Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer
Translational Cancer Research
2023;
12
(10)
:2823-2836
.
(31 October 2023)
Risk factors and a prognostic model for patients with borderline resectable locally advanced T3–4N0–1 non-small cell lung cancer: a population-based study
Translational Cancer Research
2023;
12
(10)
:2837-2851
.
(31 October 2023)
A comprehensive pan-cancer analysis identifies a novel glycolysis score and its hub genes as prognostic and immunological biomarkers
Translational Cancer Research
2023;
12
(10)
:2852-2874
.
(31 October 2023)
Decreased expression of hsa_circ_0112879 in oral squamous cell carcinoma and its clinicopathological implications
Translational Cancer Research
2023;
12
(10)
:2875-2886
.
(31 October 2023)
A deep learning-based model (DeepMPM) to help predict survival in patients with malignant pleural mesothelioma
Translational Cancer Research
2023;
12
(10)
:2887-2897
.
(31 October 2023)
A new prognostic model for glioblastoma multiforme based on coagulation-related genes
Translational Cancer Research
2023;
12
(10)
:2898-2910
.
(31 October 2023)
Natural product piperlongumine inhibits proliferation of oral squamous carcinoma cells by inducing ferroptosis and inhibiting intracellular antioxidant capacity
Translational Cancer Research
2023;
12
(10)
:2911-2922
.
(31 October 2023)
Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China
Translational Cancer Research
2023;
12
(10)
:2923-2931
.
(31 October 2023)
Review Article
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?
Translational Cancer Research
2023;
12
(10)
:2932-2945
.
(31 October 2023)
Case Report
Utilization of intraoperative indocyanine green fluorescence imaging to identify vascular anatomy in severe pleural adhesions in uniportal video-assisted thoracoscopic surgery: a case report
Translational Cancer Research
2023;
12
(10)
:2946-2951
.
(31 October 2023)
Coexistence of ETV6-RUNX1 and MLL aberration among pediatric acute lymphoblastic leukemia: case reports and a literature review
Translational Cancer Research
2023;
12
(10)
:2952-2958
.
(31 October 2023)
Study Protocol
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial
Translational Cancer Research
2023;
12
(10)
:2959-2967
.
(31 October 2023)
Erratum
Erratum to PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling
Translational Cancer Research
2023;
12
(10)
:2968-2969
.
(31 October 2023)
